Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Document › Details

Medigene AG. (5/24/18). "Press Release: Medigene Announces Capital Increase to Fund Immunotherapy Programs [NOT FOR UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAWS]". Pla

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 QVT Financial L.P.
  Group QVT (Group)
Products Product T cell therapy
  Product 2 investment banking
Index term Index term Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors
Persons Person Manchester, Keith (QVT 201705 Managing Director + Head Life Sciences QVT Financial LP)
  Person 2 Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     


   
Record changed: 2018-05-25

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top